Drug - International Biopharmaceutical Industry

news

Roche’s top immunotherapy prospect fails study in tough-to-treat lung cancer

Dive Brief: A drug combination including the Roche immunotherapy tiragolumab failed a Phase 3 trial in a tough-to-treat form of lung cancer, a setback for a closel...

1 April 2022 news cancer | Drug

Continue Reading →

news

Adagio plans comeback for COVID drug, but is it too late?

Dive Brief: Adagio Therapeutics said it will ask the Food and Drug Administration for emergency authorization of its COVID-19 drug after announcing Wednesday that ...

1 April 2022 news Adagio | adintrevimab

Continue Reading →

news

Vertex plans path to FDA for top drug prospect

Dive Brief: Vertex will begin late-stage testing of one of its top drug prospects later this month, announcing on Tuesday plans for a Phase 2/3 clinical trial that...

25 March 2022 news Drug | FDA

Continue Reading →

news

Pfizer claims study success for drug key to Arena buyout

Dive Brief: Pfizer said Wednesday an experimental drug central to its $7 billion purchase of Arena Pharmaceuticals succeeded in a crucial Phase 3 trial in patients...

25 March 2022 news Arena | colitis

Continue Reading →

news

Novartis wins FDA OK for radiopharmaceutical drug, cashing in on Endocyte deal

Dive Brief: Novartis has won Food and Drug Administration approval to sell a radiopharmaceutical designed to treat a form of advanced prostate cancer in a key step...

25 March 2022 news Drug | endocyte

Continue Reading →

news

How to eliminate design verification failure for your next device

If a drug delivery device fails a design verification test, the consequences can be far-reaching. If, for example, the volume of drug being delivered does not meet th...

21 March 2022 news Analytical | delivery

Continue Reading →

news

Nektar, Bristol Myers drug combination fails in late-stage melanoma trial

Dive Brief: Shares in Nektar Therapeutics fell by more than half Monday morning after the San Francisco biotech company and partner Bristol Myers Squibb disclosed ...

21 March 2022 news Biotech | Bristol Myers

Continue Reading →

news

Sanofi, with positive data in hand, to ask for approval of longer-lasting hemophilia therapy

Sanofi and its development partner, the Swedish drug company Sobi, said Wednesday they plan to submit an experimental, longer-lasting hemophilia treatment for approva...

14 March 2022 news Drug | hemophilia

Continue Reading →

news

FDA panel to review once-rejected Acadia drug for psychosis

Dive Brief: After receiving a rejection last year, Acadia said Wednesday that the Food and Drug Administration agreed to review its resubmitted application to expa...

14 March 2022 news Acadia | Alzheimer

Continue Reading →

news

Biden discusses drug prices, mental health services in annual address

In a State of the Union address Tuesday night, President Joe Biden highlighted the country's need for quality mental health services and called for action to combat r...

7 March 2022 news Biden | Drug

Continue Reading →